CN100366269C - Chinese medicine for treating AIDS - Google Patents
Chinese medicine for treating AIDS Download PDFInfo
- Publication number
- CN100366269C CN100366269C CNB2005100456829A CN200510045682A CN100366269C CN 100366269 C CN100366269 C CN 100366269C CN B2005100456829 A CNB2005100456829 A CN B2005100456829A CN 200510045682 A CN200510045682 A CN 200510045682A CN 100366269 C CN100366269 C CN 100366269C
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- chinese medicine
- aids
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine for treating AIDS, which is characterized by comprising the following raw material components in percentage by weight: 0.6 to 1.5 portions of angelica; 1.6-2.5 of astragalus; 1.6-2.5 of medlar; 1.6-2.5 of scutellaria; 1.6-2.5 of trichosanthes root; 1.6-2.5 of lightyellow sophora root; 0.6-1.5 of ox gall; 1.6-2.5 of liquorice; 1.6 to 2.5 portions of rhodiola; 0.6-1.5 of glossy privet fruit; 1.6-2.5 of forsythia coronaria; 1.6-2.5 parts of radix seu herba Tetrastigmatis Hypoglauci. Compared with the prior art, the invention has the following advantages: has small toxic and side effect, is safe and convenient to take, can obviously improve the body immunity of AIDS patients, reduce the toxic load of peripheral blood disease, effectively improve clinical symptoms, control the disease development and improve the life quality.
Description
Technical field
The invention belongs to a kind of Chinese medicine for the treatment of acquired immune deficiency syndrome (AIDS).
Background technology
The acquired immune deficiency syndrome (AIDS) propagation of stretching rapidly all over the world in recent years causes great threat to existent environment of people, and therefore, many countries are all endeavouring to study the active drug and the method for resisting acquired immune deficiency syndrome (AIDS).The medicine of treatment acquired immune deficiency syndrome (AIDS) employing and method mainly contain and take Western medicine and HAART at present.Adopt the Western medicine toxic and side effects big, nausea and vomiting occurs after HIV sufferers is taken, untoward reaction such as headache, therapeutic effect is not really desirable, and adopts the HAART expense higher, but is not inhibited for the infected's virus of HIV-2 type, and curative effect is very little.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine for the treatment of acquired immune deficiency syndrome (AIDS), toxic and side effects is little, takes safe ready, improves the immunity of organisms of HIV sufferers, reduces the peripheral blood virus load, effectively improves clinical symptoms, and the disease controlling development is improved the quality of living.
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 0.6-1.5; Radix Astragali 1.6-2.5; Fructus Lycii 1.6-2.5; Radix Scutellariae 1.6-2.5; Radix Trichosanthis 1.6-2.5; Radix Sophorae Flavescentis 1.6-2.5; Cattle gallbladder 0.6-1.5; Radix Glycyrrhizae 1.6-2.5; Radix Rhodiolae 1.6-2.5; Fructus Ligustri Lucidi 0.6-1.5; Hat leaf Fructus Forsythiae 1.6-2.5; Radix seu Herba Tetrastigmatis Hypoglauci 1.6-2.5.
Above-mentioned prescription also can add following at least a component: Radix Platycodonis 0.6-1.5; Radix Ginseng 0.6-1.5; Rhizoma Cimicifugae 0.6-1.5; Rhizoma Coptidis 1.6-2.5; Cortex Phellodendri 1.6-2.5; Herba Ephedrae 0.6-1.5; Ramulus Cinnamomi 0.6-1.5; Fructus Bruceae 0.6-1.5; Flos Sophorae 0.6-1.5; Flos Lonicerae 1.6-2.5; Radix Isatidis 1.6-2.5; Fructus Schisandrae Chinensis 0.6-1.5; Semen Momordicae 0.6-1.5; Radix Sophorae Tonkinensis 1.6-2.5; Fructus Mume 0.6-1.5; Herba Houttuyniae 0.6-1.5; Indigo Naturalis 0.6-1.5; Pig Poria 1.6-2.5; Rhizoma Curcumae Longae 0.6-1.5; Radix Paeoniae Alba 0.6-1.5; Rhizoma Atractylodis Macrocephalae 0.6-1.5; Fructus Gardeniae 0.6-1.5; Fructus Forsythiae 1.6-2.5; Radix Polygoni Multiflori 1.6-2.5.
Above-mentioned prescription is selected the Chinese herbal medicine that can effectively kill the nontoxic low toxicity of HIV virus in blood and the bone marrow on the one hand for use, as Radix Scutellariae, Radix Sophorae Flavescentis, Radix Trichosanthis, hat leaf Fructus Forsythiae, Radix seu Herba Tetrastigmatis Hypoglauci etc., select for use especially on the other hand the lymphsystem stem cell is carried out activated Chinese herbal medicine, as Fructus Ligustri Lucidi, Radix Polygoni Multiflori, the Rhizoma Atractylodis Macrocephalae etc., and the Chinese herbal medicine that improves lymphocyte quantity, as Radix Angelicae Sinensis, the Radix Astragali, Radix Ginseng, Radix Rhodiolae, Fructus Lycii, pig Poria etc.Associating compatibility by medicine is killed the many target spots of HIV virus realization, the shot theory that promptly theory of Chinese medical science proposed, and a dozen a sheet of methods realize kill virus, increase lymphocyte CD simultaneously
4, CD
8T quantity and hematopoietic stem cell quantity reach immunity function restructuring.
The present invention and prior art relatively have following advantage: toxic and side effects is little, takes safe ready, can significantly improve the immunity of organisms of HIV sufferers, reduces the peripheral blood virus load, effectively improves clinical symptoms, and the disease controlling development is improved the quality of living.
Description of drawings
Fig. 1 is that 10 routine HIV sufferers are taken 7 detections of Ai Keke capsule CD
4Result curve figure.
The specific embodiment
Embodiment one:
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 1.3; The Radix Astragali 1.7; Fructus Lycii 2.2; Radix Scutellariae 2; Radix Trichosanthis 1.5; Radix Sophorae Flavescentis 1.6; Cattle gallbladder 1; Radix Glycyrrhizae 2.2; Radix Rhodiolae 1.9; Fructus Ligustri Lucidi 0.9; Hat leaf Fructus Forsythiae 1.8; Radix seu Herba Tetrastigmatis Hypoglauci 2.4;
The raw material of prescription is made capsule by the conventional processing technology of capsule.
Embodiment two:
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 0.9; The Radix Astragali 2.2; Fructus Lycii 1.9; Radix Scutellariae 2.1; Radix Trichosanthis 2.1; Radix Sophorae Flavescentis 1.7; Cattle gallbladder 0.8; Radix Glycyrrhizae 2.1; Radix Rhodiolae 2.0; Fructus Ligustri Lucidi 0.7; Hat leaf Fructus Forsythiae 2.1; Radix seu Herba Tetrastigmatis Hypoglauci 2.4.
The raw material of prescription is made capsule by the conventional processing technology of capsule.
Embodiment three:
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 1.5; The Radix Astragali 2.4; Fructus Lycii 2.3; Radix Scutellariae 1.7; Radix Trichosanthis 2.4; Radix Sophorae Flavescentis 1.9; Cattle gallbladder 1.3; Radix Glycyrrhizae 2.5; Radix Rhodiolae 1.6; Fructus Ligustri Lucidi 1.1; Hat leaf Fructus Forsythiae 2.0; Radix seu Herba Tetrastigmatis Hypoglauci 1.8.
The raw material of prescription is made capsule, oral liquid or other dosage form by the conventional processing technology of capsule.
Embodiment four:
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 1.0; The Radix Astragali 1.2; Fructus Lycii 2.0; Radix Scutellariae 2.0; Radix Trichosanthis 1.7; Radix Sophorae Flavescentis 1.9; Cattle gallbladder 0.6; Radix Glycyrrhizae 1.7; Radix Rhodiolae 2.0; Fructus Ligustri Lucidi 1.0; Hat leaf Fructus Forsythiae 2.0; Radix seu Herba Tetrastigmatis Hypoglauci 2.2; Cortex Phellodendri 1.6-2.5.
The raw material of prescription is made capsule, oral liquid or other dosage form by the conventional processing technology of capsule.
Embodiment five:
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 1.0; The Radix Astragali 2.0; Fructus Lycii 1.5; Radix Scutellariae 1.9; Radix Trichosanthis 1.8; Radix Sophorae Flavescentis 1.6; Cattle gallbladder 0.9; Radix Glycyrrhizae 1.7; Radix Rhodiolae 1.9; Fructus Ligustri Lucidi 1.2; Hat leaf Fructus Forsythiae 1.9; Radix seu Herba Tetrastigmatis Hypoglauci 2.0; Radix Platycodonis 0.6-1.5; Radix Ginseng 0.6-0.9; Rhizoma Cimicifugae 0.9-1.5; Fructus Bruceae 0.6-1.5.
The raw material of prescription is made capsule, oral liquid or other dosage form by the conventional processing technology of capsule.
Embodiment six:
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 0.6; The Radix Astragali 2.1; Fructus Lycii 2.0; Radix Scutellariae 1.6; Radix Trichosanthis 2.0; Radix Sophorae Flavescentis 2.2; Cattle gallbladder 1.1; Radix Glycyrrhizae 2.0; Radix Rhodiolae 1.8; Fructus Ligustri Lucidi 1.0; Hat leaf Fructus Forsythiae 2.0; Radix seu Herba Tetrastigmatis Hypoglauci 2.3; Rhizoma Coptidis 1.6-2.0; Herba Ephedrae 0.6-1.0; Ramulus Cinnamomi 0.6-1.5; Pig Poria 1.6-2.0; Flos Sophorae 0.6-1.0; Flos Lonicerae 1.6-2.5.
The raw material of prescription is made capsule, oral liquid or other dosage form by the conventional processing technology of capsule.
Embodiment seven:
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 0.9; The Radix Astragali 2.2; Fructus Lycii 1.9; Radix Scutellariae 2.1; Radix Trichosanthis 2.1; Radix Sophorae Flavescentis 1.7; Cattle gallbladder 0.8; Radix Glycyrrhizae 2.1; Radix Rhodiolae 2.0; Fructus Ligustri Lucidi 0.7; Hat leaf Fructus Forsythiae 2.1; Radix seu Herba Tetrastigmatis Hypoglauci 2.4; Radix Ginseng 1.0-1.5; Radix Isatidis 1.6-2.5; Fructus Schisandrae Chinensis 0.6-1.5; Radix Sophorae Tonkinensis 1.6-2.0; Fructus Mume 0.6-1.5; Flos Lonicerae 1.6-2.0; Pig Poria 1.9-2.5; Fructus Forsythiae 2.0-2.5; Radix Polygoni Multiflori 1.6-2.0.
The raw material of prescription is made capsule, oral liquid or other dosage form by the conventional processing technology of capsule.
Embodiment eight:
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 1.1; The Radix Astragali 1.8; Fructus Lycii 1.7; Radix Scutellariae 2.2; Radix Trichosanthis 1.7; Radix Sophorae Flavescentis 2.2; Cattle gallbladder 0.7; Radix Glycyrrhizae 2.4; Radix Rhodiolae 2.3; Fructus Ligustri Lucidi 1.3; Hat leaf Fructus Forsythiae 2.3; Radix seu Herba Tetrastigmatis Hypoglauci 1.6; Rhizoma Coptidis 2.0-2.5; Flos Sophorae 1.0-1.5; Semen Momordicae 0.6-1.5; Herba Houttuyniae 0.6-1.5; Radix Paeoniae Alba 0.6-1.5; Radix Platycodonis 0.6-1.0; Ramulus Cinnamomi 1.0-1.5; Fructus Bruceae 0.9-1.3; Radix Isatidis 1.0-2.5; Fructus Schisandrae Chinensis 0.6-1.0; Radix Polygoni Multiflori 1.6-2.0.
The raw material of prescription is made capsule, oral liquid or other dosage form by the conventional processing technology of capsule.
Embodiment nine:
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 1.5; The Radix Astragali 2.4; Fructus Lycii 2.3; Radix Scutellariae 1.7; Radix Trichosanthis 2.4; Radix Sophorae Flavescentis 1.9; Cattle gallbladder 1.3; Radix Glycyrrhizae 2.5; Radix Rhodiolae 1.6; Fructus Ligustri Lucidi 1.1; Hat leaf Fructus Forsythiae 2.0; Radix seu Herba Tetrastigmatis Hypoglauci 1.8; Radix Ginseng 1.0-1.5; Cortex Phellodendri 1.0-2.5; Pig Poria 2.0-2.5; Rhizoma Curcumae Longae 0.6-1.5; Radix Paeoniae Alba 0.6-1.5; Fructus Gardeniae 0.6-1.5; Fructus Forsythiae 1.6-2.5.
The raw material of prescription is made capsule, oral liquid or other dosage form by the conventional processing technology of capsule.
Embodiment ten:
Raw material of Chinese medicine component provided by the invention and part by weight are as follows:
Radix Angelicae Sinensis 1.0; The Radix Astragali 2.0; Fructus Lycii 2.6; Radix Scutellariae 2.0; Radix Trichosanthis 2.0; Radix Sophorae Flavescentis 1.7; Cattle gallbladder 1.2; Radix Glycyrrhizae 1.6; Radix Rhodiolae 2.4; Fructus Ligustri Lucidi 1.5; Hat leaf Fructus Forsythiae 2.5; Radix seu Herba Tetrastigmatis Hypoglauci 2.1; Herba Ephedrae 1.0-1.5; Flos Sophorae 1.0-1.5; Radix Sophorae Tonkinensis 2.0-2.5; Fructus Mume 0.6-1.5; Herba Houttuyniae 0.6-1.5; Indigo Naturalis 0.6-1.5; Rhizoma Atractylodis Macrocephalae 0.6-1.5; Radix Polygoni Multiflori 1.6-2.5.
The raw material of prescription is made capsule, oral liquid or other dosage form by the conventional processing technology of capsule.
Chinese medicine provided by the invention is made capsule (Ai Keke capsule) and is made clinical efficacy of medicine observing on February 23rd, 2004 to November 5 in disease prevention and control center, Henan Province std aids study on prevention, carries out CD in 30 routine HIV sufferers before the treatment
4T lymphocyte and routine blood test detect, and filter out 10 routine qualified HIV sufferers as study subject, its male's 3 examples, and women's seven examples, average year makes 41.7 years old.CD
4＜300/
UI person's 4 examples, CD
4＞300/
UI person's 6 examples; Took 3 examples of antiviral drugs, 7 examples of not taken.This 10 routine HIV sufferers is the nineteen ninety-five cause and sells blood plasma and infected, and detects through the disease prevention and control center, Henan Province and to confirm as the HIV antibody positive, and tangible clinical symptoms performance is all arranged.
Subordinate list 1:10 example HIV/AIDS takes 7 CD of Ai Keke capsule
4Testing result and comparison
Subordinate list 2:10 example HIV/AIDS takes 3 virus load testing results of Ai Keke capsule and comparison
See attached list 1, to 10 routine HIV sufferers carry out zero detect after, according to every day 3 times, the therapeutic scheme of each 10 oral Chinese medicinal capsules of the present invention carries out CD after 3 months
4, virus load the 2nd time detects, and finds 10 routine experimenters' CD
4Value generally descends, and sick degree carrying capacity rises 3 times than zero detection.Therefore since five month by every day 3 times, take CD in subsequently 4 months for each 15
4Value rises gradually, detects ratio, average every routine CD with zero in 8 months
4The T lymphocyte increase by 81/
UI, average rate of increase 20.69% (seeing attached list 2), and detect for the 3rd time with the zero virus load value that detects and compare, 7 examples descend, 3 examples rise, this 3 example was all taken homemade antiviral drugs before using this Chinese medicine, and compared with the 2nd time for the 3rd time, except that 1 routine virus load raises, all the other 9 examples all descend, wherein two examples reach the level that detection does not go out, and 4 routine decline scope are arranged near 10 times, have 3 examples to descend 3 times.Before and after the clinical symptoms treatment relatively: 2 examples of generating heat for a long time, 1 example of suffering from diarrhoea, erythra 8 examples are unable to leave the bed 1 example.Through treatment, above-mentioned symptom all obtains curing (clinical observation in every month record is arranged), and body weight 100% increase, on average increases by 4.5 kilograms, and it is normal that every conventional index recovers.According to clinical observation with follow up a case by regular visits to, above-mentioned 10 routine experimenters treatment after 8 months clinical symptoms obviously improve, in order, take care of oneself and can participate in productive labor.
Conclusion: through preliminary efficacy of medicine observing, Chinese medicine provided by the invention can improve the immunity of organisms of HIV sufferers, reduces the peripheral blood virus load, effectively improve clinical symptoms, the disease controlling development is improved the quality of living, and have no side effect, take safe ready.
Claims (2)
1. Chinese medicine for the treatment of acquired immune deficiency syndrome (AIDS), it is characterized in that: raw material components and part by weight are as follows:
Radix Angelicae Sinensis 0.6-1.5; Radix Astragali 1.6-2.5; Fructus Lycii 1.6-2.5; Radix Scutellariae 1.6-2.5; Radix Trichosanthis 1.6-2.5; Radix Sophorae Flavescentis 1.6-2.5; Cattle gallbladder 0.6-1.5; Radix Glycyrrhizae 1.6-2.5; Radix Rhodiolae 1.6-2.5; Fructus Ligustri Lucidi 0.6-1.5; Hat leaf Fructus Forsythiae 1.6-2.5; Radix seu Herba Tetrastigmatis Hypoglauci 1.6-2.5.
2. the Chinese medicine of treatment acquired immune deficiency syndrome (AIDS) according to claim 1 is characterized in that prescription also can add following at least a component, and its part by weight is as follows:
Radix Platycodonis 0.6-1.5; Radix Ginseng 0.6-1.5; Rhizoma Cimicifugae 0.6-1.5; Rhizoma Coptidis 1.6-2.5; Cortex Phellodendri 1.6-2.5; Herba Ephedrae 0.6-1.5; Ramulus Cinnamomi 0.6-1.5; Fructus Bruceae 0.6-1.5; Flos Sophorae 0.6-1.5; Flos Lonicerae 1.6-2.5; Radix Isatidis 1.6-2.5; Fructus Schisandrae Chinensis 0.6-1.5; Semen Momordicae 0.6-1.5; Radix Sophorae Tonkinensis 1.6-2.5; Fructus Mume 0.6-1.5; Herba Houttuyniae 0.6-1.5; Indigo Naturalis 0.6-1.5; Pig Poria 1.6-2.5; Rhizoma Curcumae Longae 0.6-1.5; Radix Paeoniae Alba 0.6-1.5; Rhizoma Atractylodis Macrocephalae 0.6-1.5; Fructus Gardeniae 0.6-1.5; Fructus Forsythiae 1.6-2.5; Radix Polygoni Multiflori 1.6-2.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100456829A CN100366269C (en) | 2005-01-18 | 2005-01-18 | Chinese medicine for treating AIDS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100456829A CN100366269C (en) | 2005-01-18 | 2005-01-18 | Chinese medicine for treating AIDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1806834A CN1806834A (en) | 2006-07-26 |
| CN100366269C true CN100366269C (en) | 2008-02-06 |
Family
ID=36839044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100456829A Expired - Fee Related CN100366269C (en) | 2005-01-18 | 2005-01-18 | Chinese medicine for treating AIDS |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100366269C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101450173B (en) * | 2007-12-07 | 2011-09-21 | 湖南炎帝生物工程有限公司 | Traditional Chinese medicine composition and preparation method and use thereof |
| CN102335248A (en) * | 2010-07-26 | 2012-02-01 | 湖南普道医药技术有限公司 | Antivirus traditional Chinese medicinal composition and preparation method thereof |
| CN104645173A (en) * | 2015-01-30 | 2015-05-27 | 刘大荣 | Drug for treatment or adjuvant treatment of AIDS (Acquired Immune Deficiency Syndrome), and preparation method and use method thereof |
| CN105381260A (en) * | 2015-12-18 | 2016-03-09 | 颜奎峰 | Traditional Chinese medicine for treating acquired immune deficiency syndrome and preparation method thereof |
| CN106421299A (en) * | 2016-08-30 | 2017-02-22 | 雷大鹏 | Oral liquids for treating secondary immunodeficiency diseases |
| CN106377718A (en) * | 2016-11-11 | 2017-02-08 | 东莞市百替生物科技有限公司 | Traditional Chinese medicine composition for treating herpes zoster and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1145240A (en) * | 1996-05-31 | 1997-03-19 | 黄英秀 | Medicinal compsn. for prevention of Aids virus and cancer |
| CN1245707A (en) * | 1999-08-12 | 2000-03-01 | 黄英秀 | Chinese medicine for curing AIDS and carcinomatosis |
-
2005
- 2005-01-18 CN CNB2005100456829A patent/CN100366269C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1145240A (en) * | 1996-05-31 | 1997-03-19 | 黄英秀 | Medicinal compsn. for prevention of Aids virus and cancer |
| CN1245707A (en) * | 1999-08-12 | 2000-03-01 | 黄英秀 | Chinese medicine for curing AIDS and carcinomatosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1806834A (en) | 2006-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100356972C (en) | Chinese medicine for treating amblyopia and myopia | |
| CN102755594A (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
| CN1475229A (en) | Antifatigue compound Chinese medicine prescription and its preparation method | |
| CN101062339A (en) | Medicine for treating diabetes | |
| CN100366269C (en) | Chinese medicine for treating AIDS | |
| CN102698207A (en) | Traditional Chinese medicine composition for treating hepatopathy and preparation method thereof | |
| CN102178872B (en) | Chinese medicinal composition for treating uremia and preparation method thereof | |
| CN101695562B (en) | Chinese medicinal composition for treating viral hepatitis and preparation method thereof | |
| CN102657736A (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN1066628C (en) | Medicine for chronic hepatitis B and its preparation | |
| CN101199749A (en) | Chinese medicine for treating AIDS | |
| CN101732484A (en) | Capsule for restoring vital energy and producing blood | |
| CN101461857B (en) | Medicament for treating severe hepatitis | |
| CN103142914B (en) | Traditional Chinese medicine for lowering blood sugar | |
| CN102872353B (en) | Medicament for treating hypertension dizzy | |
| CN102727732B (en) | Traditional Chinese medicine composition for treating immunoiogical sterility and application of traditional Chinese medicine composition in preparing medicine for treating immunoiogical sterility | |
| CN102488851B (en) | Drug for treating recurrent genital herpes and preparation method thereof | |
| CN118416165B (en) | Chinese medicinal preparation for treating AIDS and its preparation method | |
| CN101829213B (en) | Medicine composition for treating asthma and preparation method thereof | |
| CN102727731B (en) | Preparation method of traditional Chinese medicine composition for treating immune infertility | |
| CN1772160A (en) | Chinese medicine prepn for treating immunological sterility | |
| CN118717889A (en) | A Chinese medicine composition for treating primary Sjögren's syndrome and its application | |
| CN102028877B (en) | Medicine for treating TORCH infection syndrome | |
| CN105079580A (en) | Traditional Chinese medicine composition for treating wind-warm lung-heat disease | |
| CN1279074A (en) | Chinese-medicinal pill 'Ganxuetong' |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080206 Termination date: 20140118 |